Decreased exercise tolerance during treatment was linked with greater lean body mass loss in both groups, but to a greater extent in tirzepatide-treated patients
In an integrated analysis of 2 global Phase 3 studies, we evaluated HCC incidence and risk at 8 years (Week 384) in CHB patients treated solely with TAF and those treated initially with TDF and then switched to TAF for up to 6 years (y)
When insulin/GLP-1RA fixed-ratio combinations are compared with basal insulin, a superiority in reducing HbA1c is observed, with overall benefit also in weight neutrality or weight loss, reduced hypoglycemia risk, and reduced insulin-dose requirement [19, 25,26,27, 30, 31]
Otherwise, there is nothing notable about vitamin B12 and its side effects